These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27080176)

  • 1. Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists.
    Witt JO; McCollum AL; Hurtado MA; Huseman ED; Jeffries DE; Temple KJ; Plumley HC; Blobaum AL; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2016 May; 26(10):2481-2488. PubMed ID: 27080176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D
    Jeffries DE; Witt JO; McCollum AL; Temple KJ; Hurtado MA; Harp JM; Blobaum AL; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5757-5764. PubMed ID: 28327307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and characterization of benzyloxy piperidine based dopamine 4 receptor antagonists.
    Tolentino KT; Mashinson V; Vadukoot AK; Hopkins CR
    Bioorg Med Chem Lett; 2022 Apr; 61():128615. PubMed ID: 35151866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M; Cowart MD; Hsieh GC; Miller L; Uchic ME; Chang R; Terranova MA; Donnelly-Roberts DL; Namovic MT; Miller TR; Wetter JM; Marsh K; Stewart AO; Brioni JD; Moreland RB
    Neuropharmacology; 2005 Jul; 49(1):112-21. PubMed ID: 15992586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
    Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD
    J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.
    Sanner MA; Chappie TA; Dunaiskis AR; Fliri AF; Desai KA; Zorn SH; Jackson ER; Johnson CG; Morrone JM; Seymour PA; Majchrzak MJ; Faraci WS; Collins JL; Duignan DB; Prete Di CC; Lee JS; Trozzi A
    Bioorg Med Chem Lett; 1998 Apr; 8(7):725-30. PubMed ID: 9871530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of dopamine D₄ receptor antagonists with planar chirality.
    Sanna F; Ortner B; Hübner H; Löber S; Tschammer N; Gmeiner P
    Bioorg Med Chem; 2013 Apr; 21(7):1680-4. PubMed ID: 23428965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent findings leading to the discovery of selective dopamine D
    Giorgioni G; Del Bello F; Pavletić P; Quaglia W; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Piergentili A
    Eur J Med Chem; 2021 Feb; 212():113141. PubMed ID: 33422983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: variations on the 1H-pyrimidin-2-one theme.
    Geneste H; Amberg W; Backfisch G; Beyerbach A; Braje WM; Delzer J; Haupt A; Hutchins CW; King LL; Sauer DR; Unger L; Wernet W
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1934-7. PubMed ID: 16439127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
    J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626.
    Vangveravong S; Taylor M; Xu J; Cui J; Calvin W; Babic S; Luedtke RR; Mach RH
    Bioorg Med Chem; 2010 Jul; 18(14):5291-300. PubMed ID: 20542439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4 Receptor with in Vivo Activity.
    Berry CB; Bubser M; Jones CK; Hayes JP; Wepy JA; Locuson CW; Daniels JS; Lindsley CW; Hopkins CR
    ACS Med Chem Lett; 2014 Sep; 5(9):1060-4. PubMed ID: 25221667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents.
    Unangst PC; Capiris T; Connor DT; Doubleday R; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
    J Med Chem; 1997 Dec; 40(25):4026-9. PubMed ID: 9406594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery of potent and selective dopamine D4 receptor antagonists.
    Faraci WS; Zorn SH; Sanner MA; Fliri A
    Curr Opin Chem Biol; 1998 Aug; 2(4):535-40. PubMed ID: 9736928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.
    Micheli F; Bonanomi G; Braggio S; Capelli AM; Celestini P; Damiani F; Di Fabio R; Donati D; Gagliardi S; Gentile G; Hamprecht D; Petrone M; Radaelli S; Tedesco G; Terreni S; Worby A; Heidbreder C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):901-7. PubMed ID: 18248991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists.
    Egle I; Barriault N; Bordeleau M; Drage J; Dube L; Peragine J; Mazzocco L; Arora J; Jarvie K; Tehim A
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4847-50. PubMed ID: 15341937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.